Studies hae shown that drug-eluting stents lower the need for repeat procedures to fewer than 10 percent of cases when they are used for FDA-approed conditions in coronary arteries.

• 被FDA批准广泛应用于冠状动脉疾病的时候，关于这种支架的研究表明，它可以将支架再植率降低到10%25。